Craig W. Lindsley, Ph.D.
Affiliations: | 2006- | Pharmacology | Vanderbilt University, Nashville, TN |
Website:
http://www.mc.vanderbilt.edu/labs/lindsley/lindsleycw.htmlGoogle:
"Craig Lindsley"Mean distance: 7.34 | S | N | B | C | P |
Parents
Sign in to add mentor| Bruce H. Lipshutz | grad student | 1996 | UC Santa Barbara |
| Matthew D. Shair | post-doc | Harvard |
Children
Sign in to add trainee| Emily Jeanne Lilla | research assistant | 2017- | Vanderbilt |
| Pedro Manuel Garcia-Barrantes | grad student | Vanderbilt | |
| Evan P. Lebois | grad student | Vanderbilt (Neurotree) | |
| Kellie D. Nance | grad student | Vanderbilt | |
| Jeanette L Bertron | grad student | 2016- | Vanderbilt |
| Richard Nathan Daniels | grad student | 2010 | Vanderbilt |
| J. Phillip Kennedy | grad student | 2010 | Vanderbilt |
| Olugbeminiyi Fadeyi | grad student | 2011 | Vanderbilt |
| Leslie N. Aldrich | grad student | 2012 | Vanderbilt |
| Sydney Lear Stoops | grad student | 2012 | Vanderbilt |
| Michael L. Schulte | grad student | 2009-2013 | Vanderbilt |
| Robert Raymond Lavieri | grad student | 2014 | Vanderbilt |
| Timothy J. Senter | grad student | 2010-2015 | Vanderbilt |
| Cody J. Wenthur | grad student | 2011-2015 | Vanderbilt |
| Caitlin N Kent | grad student | 2019-2020 | |
| Kayla J. Temple | post-doc | 2014- | Vanderbilt |
| Aaron T Garrison | post-doc | 2018-2019 | Vanderbilt |
| Melissa Alara Korkmaz-Vaisys | post-doc | 2020-2021 | Vanderbilt |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Childress ES, Capstick RA, Crocker KE, et al. (2024) Discovery of 4-(5-Membered)Heteroarylether-6-methylpicolinamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5. Acs Medicinal Chemistry Letters. 15: 2210-2219 |
| Engers JL, Baker LA, Chang S, et al. (2024) Discovery of VU6016235: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM). Acs Chemical Neuroscience. 15: 3744-54 |
| Capstick RA, Bollinger SR, Engers JL, et al. (2024) Discovery of VU6008677: A Structurally Distinct Tricyclic M Positive Allosteric Modulator with Improved CYP450 Profile. Acs Medicinal Chemistry Letters. 15: 1358-1366 |
| Dwomoh L, Rossi M, Scarpa M, et al. (2022) M muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease. Science Signaling. 15: eabm3720 |
| Luessen DJ, Gallinger IM, Ferranti AS, et al. (2022) mGlu-mediated restoration of prefrontal cortex inhibitory signaling reverses social and cognitive deficits in an NMDA hypofunction model in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
| Garrison AT, Orsi DL, Capstick RA, et al. (2022) Development of : A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder. Journal of Medicinal Chemistry |
| McClenahan SJ, Kent C, Kharade S, et al. (2022) . Molecular Pharmacology |
| Bertron JL, Duvernay MT, Mitchell SG, et al. (2021) Discovery and Optimization of a Novel Series of Competitive and Central Nervous System-Penetrant Protease-Activated Receptor 4 (PAR4) Inhibitors. Acs Chemical Neuroscience |
| Long MF, Capstick RA, Spearing PK, et al. (2021) Development of structurally distinct tricyclic M positive allosteric modulator (PAM) chemotypes - Part 2. Bioorganic & Medicinal Chemistry Letters. 128416 |
| Yamada Y, Gilliland K, Xiang Z, et al. (2021) Positive allosteric modulators (PAMs) of the group II metabotropic glutamate receptors: Design, synthesis, and evaluation as ex-vivo tool compounds. Bioorganic & Medicinal Chemistry Letters. 128342 |